Workshop D: Closing the Gap from Approval to Implementation: Reviewing Market Access, Drug Pricing, Reimbursement
Time: 1:00 pm
day: PRE-CONFERENCE WORKSHOP DAY Track B P2
Details:
With only 20% of patients being treated by approved therapies there are a huge portion of dermatology patients not receiving treatment they could benefit from. How can we best understand, break down and close this gap to ensure eligible patients can access treatment?
Key Objectives
- Learn from Case-Based Presentations: Exploring successes and learnings in implementation science
- Understanding Factors Affecting Implementation: Market access, drug pricing and reimbursement, adoption by prescribers and patients
- Navigating Access Challenges That Patients May Face: Including strictness of inclusion/exclusion criteria, geographic location, and more
- Understanding Patient Preference: Considering delivery routes such as systemic, oral, or topical options
- Getting Clinician Buy-In: Focusing on HCP education and engagement to understand and address barriers to implementation
